Umoja Rebranding and Website

Umoja Biopharma is a biopharmaceutical company developing a revolutionary new class of CAR T cell therapy that has the potential to transform the way a patient’s body fights cancer. The company has created an entirely new class of immunotherapies to retool a patient’s immune system in vivo—the therapy is manufactured within the body as opposed to in a lab—freeing patients from the burdens of other immuno-oncology treatments and expanding access to treatment for more cancer patients. Other than their logo, Umoja was in need of a comprehensive brand redesign. This included concepting and designing a visual system and then using those components to craft an investor-focused corporate presentation, brand identity collateral, and a website.